The article presents information about the growth of multi-billion dollar pharmaceutical industry PLIVA d.d. and its inexperienced social power. It mentions about the result of its implications of consumer rights cuts over consumers and stakeholders. It also states the solution against the decision of the company that can change the landscape of powerful and profitable pharmacy companies.